Clinical Trial Update: The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating oral nanocurcumin as adjuvant therapy for anogenital warts, focusing on clinical improvement and immunological biomarkers NF-κB, IFN-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Warts

Drugs mentioned

• Nanocurcumin (curcumin nanoparticle formulation)

Snippet

Sponsor: Indonesia University | Conditions: Anogenital Wart | Phase 2, Phase 3 | Status: COMPLETED